The Relationship Between Age at Diabetes Onset and Clinical Outcomes in Newly Diagnosed Type 2 Diabetes: A Real-World Two-Center Study
Mengdie Chen,Ping Feng,Yao Liang,Xun Ye,Yiyun Wang,Qiao Liu,Chaoyin Lu,Qidong Zheng,Lijing Wu
DOI: https://doi.org/10.2147/dmso.s485967
2024-10-29
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Mengdie Chen, 1 Ping Feng, 1 Yao Liang, 2 Xun Ye, 3 Yiyun Wang, 2 Qiao Liu, 1 Chaoyin Lu, 1 Qidong Zheng, 2 Lijing Wu 2 1 Department of Endocrinology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, People's Republic of China; 2 Department of Internal Medicine, Yuhuan Second People's Hospital, Yuhuan, Zhejiang, People's Republic of China; 3 Department of Endocrinology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China Correspondence: Lijing Wu, Department of Internal Medicine, Yuhuan Second People's Hospital, No.77, Environmental Protection Middle Road, Chu Men Town, Yuhuan, Zhejiang, 317600, People's Republic of China, Tel: +86-13777603508, Email Purpose: This study was developed with the goal of clarifying whether there is any relationship between type 2 diabetes mellitus (T2DM) age of onset and clinical outcomes for patients in National Metabolic Management Centers (MMC). Patients and Methods: From September 2017 - June 2022, 864 total T2DM patients were recruited in MMC and assigned to those with early-onset and late-onset diabetes (EOD and LOD) based on whether their age at disease onset was ≤ 40 or > 40 years. All patients received standardized management. Baseline and 1-year follow-up data from these two groups of patients were assessed. Associations between onset age and other factors were evaluated with a multivariate linear regression approach, adjusting for appropriate covariates. Outcomes in particular subgroups were also assessed in stratified analyses. Results: Markers of dysregulated glucose metabolism and BMI values were significantly higher among EOD patients as compared to LOD patients. Subjects in both groups exhibited significant improvements in several disease-related parameters on 1-year follow-up after undergoing metabolic management. EOD patients exhibited significantly greater percentage reductions in HbA1c levels (− 28.49 (− 44.26, − 6.45)% vs − 13.70 (− 30.15,-1.60)%, P =0.017) relative to LOD patients following adjustment for confounders. Significant differences were also detected between these groups when focused on subgroups of patients who were male, exhibited a BMI ≥ 25, an HbA1c ≥ 9, or had a follow-up frequency < 2. Conclusion: Data from a 1-year follow-up time point suggest that a standardized metabolic disease management model can promote effective metabolic control in newly diagnosed T2DM patients, particularly among individuals with EOD. Keywords: age of onset, disease management, type 2 diabetes Diabetes is among the most common global forms of chronic disease, and is forecast to affect approximately 700 million people as of 2045. 1 Type 2 diabetes mellitus (T2DM) affects 11.2% of individuals in China over the age of 18, 2 resulting in massive economic costs for the Chinese healthcare system. 3 Persistent hyperglycemia can result in extensive damage the the vasculature, kidneys, nerves, kidneys, and cardiovascular system, leading to multi-systemic adverse complications. 4 Effective long-term glycemic control is necessary to prevent the onset of macrovascular and microvascular complications in individuals with diabetes, leading to the consumption of substantial medical resources in order to provide patients with appropriate care. 5,6 The age at diabetes onset is becoming progressively younger at the global level, with a steady increase in the proportion of diabetic patients who are young or middle-aged. 7,8 Roughly 18% of Asian adults with T2DM have early-onset disease according to the Joint Asia Diabetes Evaluation (JADE) program, 9 and the respective prevalence rates of T2DM among individuals in China who are 18–29 and 30–39 years of age are 4.5% and 6.6%, while the rates of prediabetes among individuals under 40 years of age can reach 40–50%. 10 Early-onset diabetes (EOD) is defined by an early age of diagnosis, although different studies use age thresholds anywhere from 30–45 years, 11 with 40 years of age being the most common cut-off 12 Emerging data suggest that EOD may be more aggressive than late-onset diabetes (LOD), resulting in characteristically more rapid β-cell functional deterioration, the need for insulin treatment with greater frequency, and the potential for more common microvascular and macrovascular complications. 13 Indeed, EOD patients exhibit metabolic disorders and diabetic complications more severe than those of LOD patients. 14 Early-onset T2DM has also been linked to greater cardiovascular disease risk, morbidity, and mortality relative to T -Abstract Truncated-
endocrinology & metabolism